Active Wellness: Search, Learn & Order Drugs with ActiveMED

40mg , Injectible
Manufacture: CBC
Rating:

55.00
Qty:
IN STOCK

Substitutes

Add Another Drug

Brand Name	Price	Pack	Save (₹)	Manufacturer
Inj, PANTIUM Comp: (Pantoprazole 40mg )	44.95	1	-10.05	INTAS PHARMACEUTICALS PVT LTD
Inj, ZEPOXIN Comp: (Pantoprazole 40mg )	49.50	1	-5.50	NEON LABORATORIES PVT LTD
Inj, PAZOL Comp: (Pantoprazole 40mg )	50.00	1	-5.00	WYKAY PHARMA
Inj, GEPANTO Comp: (Pantoprazole 40mg )	50.33	1	-4.67	GOPAL LIFESCIENCES
Inj, PANTOPAZ Comp: (Pantoprazole 40mg )	51.00	1	-4.00	AGLOWMED
Inj, ENPEN Comp: (Pantoprazole 40mg )	52.00	1	-3.00	ENDURANCE HEALTHCARE
Inj, TOP-S Comp: (Pantoprazole 40mg )	52.00	1	-3.00	SHRI NIVAS (GUJ) LAB. (P) LTD.
Inj, PANSA Comp: (Pantoprazole 40mg )	52.50	1	-2.50	ZUVENTUS

Description

Pantoprazole is a proton pump inhibitor drug. It rapidly absorbed after oral administration. The drug is subject low first pass hepatic extraction, displaying an estimated absolute oral bioavailability of 73%. It is being excreted as urinary metabolites, the reminder is exerted in the faeces and originate primarily from biliary secretion, It is more stable than omeprazole.

Indications

Gastric ulcer
Reflux esophagitis
Ulcer, Duodenal
Zollinger Ellison Syndrome

Side Effects

Diarrhea
Dizziness
GI Infections
Pruritus

Precautions

Children below 12 years of age
Pregnancy

Contraindications

Hypersensitivity to drug

Interactions

Interact Type	Severity
Concomitant use should be avoided Atazanavir	Severe
Concomitant use should be avoided Dasatinib	Severe
Concomitant use should be avoided Erlotinib	Severe
Increases blood levels Methotrexate	Severe
Decrease Absorption Nelfinavir	Severe
Decrease Absorption Rilpivirine	Severe

Consumption Details

Route/Form	Dose	Age	Days
Oral/ Tablets	40mg	Any All	2-8 weeks
Oral/ Tablets	40mg	Any All	2-8 weeks
Oral/ Tablets	40mg	Any All	2-8 weeks
Oral/ Tablets	40mg	Any All	2-8 weeks

Safety in pregnancy

Pantoprazole (PANPROZOLE) falls in Category B

Pregnancy Category	Description
Category B	Either Animal-Reproduction studies have not demonstrated a foetal risk, but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
Category B	Either Animal-Reproduction studies have not demonstrated a foetal risk, but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).

Pantoprazole (PANPROZOLE)